News

2021

• January 4, 2021

  Domain Therapeutics to participate in the J.P. Morgan 39th Annual Healthcare Conference 2021 DIGITAL

  Read more

2020

• December 1, 2020

  Meet&Match 2020 immuno-oncology

  Read more
• October 20, 2020

  BIO-EUROPE 2020 digital meeting

  Read more
• October 13, 2020

  Join our free webinar : Innovative Technology for Insights into Receptor Tyrosine Kinase Biology on Oct. 29, 2020 at 11 am EST

  Read more
• October 5, 2020

  Domain therapeutics webinar : Shedding New Light on GPCR Drug Discovery with a Novel Biosensor Technology

  Read more
• September 8, 2020

  Join our free webinar : Shedding new light on GPCR drug discovery with a novel biosensor technology on Sept. 29, 2020 at 11 am EST

  Read more
• June 19, 2020

  Domain presents the last generation of bioSens-All™ platform dedicated to checkpoint inhibitors at the AACR 2020

  Read more
• June 19, 2020

  Domain presents a novel approach to study RTK mutations and the effects of inhibitors at the AACR 2020

  Read more
• June 19, 2020

  Domain presents target identification strategy to identify novel immune checkpoint from GPCR-ome at the AACR 2020

  Read more
• June 19, 2020

  Domain presents the best-in-class potential of its EP4 antagonist drug candidate at the AACR 2020

  Read more
• June 10, 2020

  Domain Therapeutics contributes to the launch of Find Therapeutics

  Read more
• June 9, 2020

  DOMAIN at the BIO Digital conference 2020

  Read more
• April 10, 2020

  Domain at the BioTrinity 2020 digital conference

  Read more
• January 13, 2020

  Domain at the JP Morgan Healthcare conference

  Read more